Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
Gabriela Dumitrița Stanciu, Andrei Luca, Răzvan Nicolae Rusu, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 40-40
Open Access | Times Cited: 224

Showing 1-25 of 224 citing articles:

Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders
Yijing Chen, Jinying Xu, Yu Chen
Nutrients (2021) Vol. 13, Iss. 6, pp. 2099-2099
Open Access | Times Cited: 530
Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences
Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 176
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 156
Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
Xiaohang Qian, Xiaoxuan Song, Xiaoli Liu, et al.
Ageing Research Reviews (2021) Vol. 68, pp. 101317-101317
Closed Access | Times Cited: 121
COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xiaohuan Xia, Yi Wang, Jialin Zheng
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 119
The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
Immacolata Vecchio, Luca Sorrentino, Anna Maria Paoletti, et al.
Journal of Central Nervous System Disease (2021) Vol. 13
Open Access | Times Cited: 111
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Shaochang Wu, Xia Liu, Ruilai Jiang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 106
Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
Rami J. Obaid, Nafeesa Naeem, Ehsan Ullah Mughal, et al.
RSC Advances (2022) Vol. 12, Iss. 31, pp. 19764-19855
Open Access | Times Cited: 85
Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 82
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
Mohammad Nasb, Weichu Tao, Ning Chen
Aging and Disease (2023)
Open Access | Times Cited: 66
Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach
Luciane B. Silva, Elenilze F. B. Ferreira, Maryam Maryam, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1035-1035
Open Access | Times Cited: 43
Green synthesis of zinc oxide nanoparticles using aqueous extract of shilajit and their anticancer activity against HeLa cells
Parthasarathi Perumal, Nazeer Ahamed Sathakkathulla, Kalaivani Kumaran, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Evaluating the antioxidant, anti‐inflammatory, and neuroprotective potential of fruiting body and mycelium extracts from edible yellow morel (Morchella esculenta L. Pers.)
Rida Haider, Luisa Agnello, Shahid Masood Shah, et al.
Journal of Food Science (2025) Vol. 90, Iss. 1
Open Access | Times Cited: 2
Exploration of natural products for the development of promising Cholinesterase inhibitors in Alzheimer’s disease treatment
Hassan Nour, Oussama Abchır, Nouh Mounadi, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42479-e42479
Open Access | Times Cited: 2
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Mohammad Azizur Rahman, Kamrul Islam, Saidur Rahman, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 3, pp. 1017-1023
Open Access | Times Cited: 112
Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages
Gabriela Dumitrița Stanciu, Veronica Bild, Daniela Carmen Ababei, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 6, pp. 1713-1713
Open Access | Times Cited: 88
De Novo Drug Design of Targeted Chemical Libraries Based on Artificial Intelligence and Pair-Based Multiobjective Optimization
Domenico Alberga, Nicola Gambacorta, Daniela Trisciuzzi, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 10, pp. 4582-4593
Closed Access | Times Cited: 78
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
Jiaojiao Wu, Yang Yu, Yan Wan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113207-113207
Open Access | Times Cited: 68
Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling
Pooja Jadiya, Joanne F. Garbincius, John W. Elrod
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Long-term exercise pre-training attenuates Alzheimer’s disease–related pathology in a transgenic rat model of Alzheimer’s disease
Luodan Yang, Chongyun Wu, Yong Li, et al.
GeroScience (2022) Vol. 44, Iss. 3, pp. 1457-1477
Open Access | Times Cited: 60
Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer’s Disease
Marta Campora, Valeria Francesconi, Silvia Schenone, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 1, pp. 33-33
Open Access | Times Cited: 59
Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease
Kang Qian, Xiaoyan Bao, Yixian Li, et al.
ACS Nano (2022) Vol. 16, Iss. 7, pp. 11455-11472
Closed Access | Times Cited: 57
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease
Honghua Zhang, Yuying Wang, Yuqing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114606-114606
Closed Access | Times Cited: 55
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du, Xiaoyu Meng, Yao Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 51
Mechanisms and treatment strategies of organophosphate pesticide induced neurotoxicity in humans: A critical appraisal
Shahid Yousuf Ganie, Darakhshan Javaid, Younis Ahmad Hajam, et al.
Toxicology (2022) Vol. 472, pp. 153181-153181
Closed Access | Times Cited: 46
Page 1 - Next Page

Scroll to top